Skip to main content
. 2019 Nov 27;19:225. doi: 10.1186/s12890-019-0983-7

Table 1.

demographics, clinical manifestations, imaging features of Takayasu’s arteritis patients with pulmonary arteritis

total (n = 51) non-PH (n = 21) PH (n = 30) P
Sex (female) 39 (76.5%) 15 (71.4%) 24 (80%) 0.518
Age (year) 33 (14–67) 30 (15–65) 35.5 (22–67) 0.196
Median duration of disease (months) 28 (1–540) 17 (1–120) 45.5 (1–540) 0.009*
Clinical symptoms
 Cough 34 (66.7%) 15 (71.4%) 19 (63.3%) 0.546
 Hemoptysis 24 (47.1%) 14 (66.7%) 10 (33.3%) 0.019*
 Dyspnea 36 (70.6%) 11 (52.4%) 25 (83.3%) 0.017*
 Chest pain 23 (45.1%) 15 (71.4%) 8 (26.7%) 0.002*
 Palpitation 12 (23.5%) 4 (19.0%) 8 (26.7%) 0.767
 Fever 22 (43.1%) 13 (61.9%) 9 (30.0%) 0.024*
Lab tests
 WBC (×109/L) 9.07 (4.06–18.46) 9.80 (8.92–17.00) 8.48 (4.06–18.46) 0.246
 ESR (mm/h) 16 (1–178) 34 (2–178) 8.5 (1–140) 0.027*
 CRP (mg/dL) 7.17 (0.11–238.31) 13.7 (0.37–238.31) 5.65 (0.11–155.00) 0.284
Radiological features
 Cavity 7 (13.7%) 5 (23.8%) 2 (6.7%) 0.181
 Nodule 25 (49.0%) 11 (52.4%) 14 (46.7%) 0.688
 Pleural thickening 27 (52.9%) 10 (47.6%) 17 (56.7%) 0.524
 irregular linear opacities 26 (51.0%) 11 (52.4%) 15 (50.0%) 0.867
 Patchy opacities 27 (52.9%) 12 (57.1%) 15 (50.0%) 0.615
 Subpleural wedge-shaped shadow 13 (25.5%) 10 (42.9%) 3 (10.0%) 0.002*
 Mosaic perfusion 3 (5.9%) 0 3 (10.0%) 0.259
Extrapulmonary vascular involvement 39 (76.5%) 13 (61.9%) 26 (86.7%) 0.040*
 Aorta 25 (49.0%) 8 (38.1%) 17 (56.7%) 0.192
 Carotid artery 32 (62.7%) 10 (47.6%) 22 (73.3%) 0.062
 Vertebral artery 6 (11.8%) 3 (14.3%) 3 (10.0%) 0.979
 Subclavian artery 30 (58.8%) 10 (47.6%) 20 (66.7%) 0.174
 Mesenteric artery 6 (11.8%) 0 6 (20.0%) 0.036*
 Renal artery 18 (35.3%) 4 (19.0%) 14 (46.7%) 0.083
 Iliac artery 3 (5.9%) 1 (4.8%) 2 (6.7%) 1.000
 Coronary artery 2 (3.9%) 1 (4.8%) 1 (3.3%) 1.000

Values in parentheses indicate percentage or range. CRP C-reactive protein, ESR Erythrocyte sedimentation rate, WBC White blood cells. *P < 0.05